My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
most popular
Latest
Buy Hold Sell
Alternatives In Focus
Series
Alternatives in Focus
Buy Hold Sell
Expert Insights
Fund in Focus
Income Series
Listed Series
Livewire Live
Meet The Adviser
Meet The Investor
Outlook Series
Rapid Fire
Reporting Season
Signal or Noise
Success and More Interesting Stuff
The Pitch
The Rules of Investing
Undiscovered Funds
Views from the Top
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Assets
Property
Weekend Report
Contributors
Find Funds
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Buy Hold Sell
Alternatives In Focus
Series
Alternatives in Focus
Buy Hold Sell
Fund in Focus
Income Series
Livewire Live
Meet The Investor
Rapid Fire
Signal or Noise
Success and More Interesting Stuff
The Pitch
The Rules of Investing
Views from the Top
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Assets
Property
Weekend Report
Find funds
Newsletter
osprey medical
Latest news and analysis on osprey medical
May 23, 2017 09:12
Executive Series - Osprey Medical (OSP) CEO, Mike
McCormick
OSP
OSPREY MEDICAL INC
ASX:OSP
Followed by
10
people
OSP
OSPREY MEDICAL INC
ASX:OSP
Followed by
10
people
CommSec
Online Stockbroker
May 23, 2017 09:12
July 26, 2016 09:29
Executive Series - Osprey Medical (OSP) CEO, Mike
McCormick
CommSec
Online Stockbroker
July 26, 2016 09:29
July 14, 2015 13:56
Medtech Companies Gained 45.6% in FY15, And A Strong FY16 Expected
Canaccord Genuity
Stockbroker
July 14, 2015 13:56
Advertisement
December 06, 2013 13:56
Cannacord rates Osprey Medical (OSP) a buy with a price target of $1.25 from the current price of around
$.69
Livewire Exclusive
Livewire Markets
December 06, 2013 13:56
4
most
popular
Equities
Worried about a downturn? Here are 7 ASX companies with resilient earnings
Sara Allen,
Livewire Markets
Equities
Don't let all time highs stop you buying this "bull"
market
Michael Carmody,
Centennial Asset Management
Equities
The US$115 billion question: Will Meta and Microsoft's huge spending on AI be worth it?
Hans Lee,
Livewire Markets
Funds
If 24 LICs ran the Melbourne Cup, which would be our favourites
Daryl Wilson,
Affluence Funds Management
view all
Advertisement
